|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 241/18 | (2006.01) |
| C07D 241/20 | (2006.01) | ||
| A61K 31/495 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Number of the document | 3094628 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15703321.8 |
| Date of filing the European patent application | 2015-01-16 | |
| (97) | Date of publication of the European application | 2016-11-23 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-08 |
| (46) | Date of publication of the claims translation | 2018-10-25 |
| (86) | Number | PCT/IB2015/050345 |
| Date | 2015-01-16 |
| (87) | Number | WO 2015/107495 |
| Date | 2015-07-23 |
| (30) | Number | Date | Country code |
| 201461928754 P | 2014-01-17 | US | |
| 201461991129 P | 2014-05-09 | US |
| (72) |
CHEN, Christine Hiu-tung, US
CHEN, Zhuoliang, US
DORE, Michael, US
FORTANET, Jorge Garcia, US
KARKI, Rajesh, US
KATO, Mitsunori, US
LAMARCHE, Matthew J., US
PEREZ, Lawrence Blas, US
SMITH, Troy Douglas, US
WILLIAMS, Sarah, US
GIRALDES, John William, US
TOURE, Bakary-barry, US
SENDZIK, Martin, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | N-Azaspirocikloalkanas, pakeistas N heteroarilo junginiais, ir kompozicijos, skirtos SHP2 aktyvumo slopinimui |
| N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 |
| Payment date | Validity (years) | Amount | |
| 2025-12-18 | 12 | 289.00 EUR |
| 2027-01-16 |